These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31112980)

  • 1. A Prediction Model for the Intraocular Pharmacokinetics of Intravitreally Injected Drugs Based on Molecular Physicochemical Properties.
    Kim HM; Park KH; Chung JY; Woo SJ
    Ophthalmic Res; 2020; 63(1):41-49. PubMed ID: 31112980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).
    Durairaj C; Shah JC; Senapati S; Kompella UB
    Pharm Res; 2009 May; 26(5):1236-60. PubMed ID: 18841448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats.
    Jakubiak P; Alvarez-Sánchez R; Fueth M; Broders O; Kettenberger H; Stubenrauch K; Caruso A
    Mol Pharm; 2021 Jun; 18(6):2208-2217. PubMed ID: 34014104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of Intra-vitreal Half-Lifes in the Rabbit Eye with Semi-mechanistic Equations.
    Schmitt W
    Pharm Res; 2017 Jan; 34(1):49-57. PubMed ID: 27628626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.
    Park SJ; Oh J; Kim YK; Park JH; Park JY; Hong HK; Park KH; Lee JE; Kim HM; Chung JY; Woo SJ
    Eye (Lond); 2015 Apr; 29(4):561-8. PubMed ID: 25592118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the vitreal half-life of small molecular drug-like compounds.
    Kidron H; Del Amo EM; Vellonen KS; Urtti A
    Pharm Res; 2012 Dec; 29(12):3302-11. PubMed ID: 22777295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys - Evidence for half-life extension by albumin.
    Fuchs H; Chen LZ; Low S; Yu H
    Exp Eye Res; 2021 Apr; 205():108486. PubMed ID: 33571529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
    Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
    Bakri SJ; Snyder MR; Reid JM; Pulido JS; Ezzat MK; Singh RJ
    Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin.
    Del Amo EM; Griffiths JR; Klaska IP; Hoke J; White A; Aarons L; Cooper GJS; Bainbridge JWB; Bishop PN; Unwin RD
    Mol Pharm; 2020 Jul; 17(7):2390-2397. PubMed ID: 32437164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intravitreal macromolecules: Scaling between rats and rabbits.
    Sadeghi A; Puranen J; Ruponen M; Valtari A; Subrizi A; Ranta VP; Toropainen E; Urtti A
    Eur J Pharm Sci; 2021 Apr; 159():105720. PubMed ID: 33465477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.
    del Amo EM; Vellonen KS; Kidron H; Urtti A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):215-26. PubMed ID: 25603198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model.
    Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Gadkar K; Mazer NA
    Mol Pharm; 2017 Aug; 14(8):2690-2696. PubMed ID: 28631484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and efficacy of intraocular flurbiprofen.
    Blazaki S; Tsika C; Tzatzarakis M; Naoumidi E; Tsatsakis A; Tsatsanis C; Tsilimbaris MK
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2375-2380. PubMed ID: 28963579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies.
    Fuchs H; Igney F
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):115-122. PubMed ID: 28055308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment.
    Haghjou N; Abdekhodaie MJ; Cheng YL
    Pharm Res; 2013 Jan; 30(1):41-59. PubMed ID: 23054085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular Pharmacokinetics of Intravitreal Aflibercept (Eylea) in a Rabbit Model.
    Park SJ; Choi Y; Na YM; Hong HK; Park JY; Park KH; Chung JY; Woo SJ
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2612-7. PubMed ID: 27258433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.
    Caruso A; Füth M; Alvarez-Sánchez R; Belli S; Diack C; Maass KF; Schwab D; Kettenberger H; Mazer NA
    Mol Pharm; 2020 Feb; 17(2):695-709. PubMed ID: 31876425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of HM-3 after intravitreal administration in mice.
    Yuan D; Shen H; Yuan S; Liu X; Xia X; Xie P; Li W; Hu J; Liu Q; Xu H
    Curr Eye Res; 2014 Aug; 39(8):837-44. PubMed ID: 24559456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.